PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $506.000K Up From $491.000K YoY

Benzinga Newsdesk www.benzinga.com Negative 80.1%

Neg 80.1% Neu 0% Pos 0%

PURE Bioscience (OTC:PURE) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $506.000 thousand in sales this quarter. This is a 3.05 percent increase over sales of $491.000 thousand the same period last year.